Summary of Study ST002044
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001291. The data can be accessed directly via it's Project DOI: 10.21228/M8V12R This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002044 |
| Study Title | An observational study of cardiovascular patients in India |
| Study Summary | Serum samples for CVD patients were analyzed by untargeted metabolomics assays to identify prognostic biomarkers. |
| Institute | Translational Health Science And Technology Institute (THSTI) |
| Last Name | Kumar |
| First Name | Yashwant |
| Address | NCR Biotech Science Cluster 3rd Milestone, Faridabad - Gurgaon Rd, Expressway, Faridabad, Haryana 121001, India |
| yashubt@gmail.com | |
| Phone | 0129-2876300 |
| Submit Date | 2021-12-22 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML |
| Analysis Type Detail | LC-MS |
| Release Date | 2022-02-08 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001291 |
| Project DOI: | doi: 10.21228/M8V12R |
| Project Title: | An observational study of cardiovascular patients in India |
| Project Summary: | Serum samples for CVD patients were analyzed by untargeted metabolomics assays to identify prognostic biomarkers. |
| Institute: | Translational Health Science And Technology Institute (THSTI) |
| Last Name: | Kumar |
| First Name: | Yashwant |
| Address: | NCR Biotech Science Cluster 3rd Milestone, Faridabad - Gurgaon Rd, Expressway, Faridabad, Haryana 121001, India |
| Email: | yashubt@gmail.com |
| Phone: | 0129-2876300 |
| Contributors: | Sadjad Baygi, Sanjay K Banerjee, Praloy Chakraborty, Dinesh Barupal |
Subject:
| Subject ID: | SU002126 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | local_sample_id | Gender |
|---|---|---|
| SA192043 | D-45 | F |
| SA192044 | D-50 | F |
| SA192045 | D-53 | F |
| SA192046 | D-43 | F |
| SA192047 | D-52 | F |
| SA192048 | D-38 | F |
| SA192049 | D-30 | F |
| SA192050 | D-188 | F |
| SA192051 | D-37 | F |
| SA192052 | D-100 | F |
| SA192053 | D-185 | F |
| SA192054 | D-176 | F |
| SA192055 | D-78 | F |
| SA192056 | D-95 | F |
| SA192057 | D-156 | F |
| SA192058 | D-168 | F |
| SA192059 | D-61 | F |
| SA192060 | D-59 | F |
| SA192061 | D-152 | F |
| SA192062 | D-57 | F |
| SA192063 | D-153 | F |
| SA192064 | D-27 | F |
| SA192065 | D-108 | F |
| SA192066 | D-15 | F |
| SA192067 | D-17 | F |
| SA192068 | D-19 | F |
| SA192069 | D-20 | F |
| SA192070 | D-14 | F |
| SA192071 | D-13 | F |
| SA192072 | D-130 | F |
| SA192073 | D-9 | F |
| SA192074 | D-10 | F |
| SA192075 | D-122 | F |
| SA192076 | D-120 | F |
| SA192077 | D-18 | F |
| SA192078 | D-24 | F |
| SA192079 | D-155 | M |
| SA192080 | D-132 | M |
| SA192081 | D-154 | M |
| SA192082 | D-140 | M |
| SA192083 | D-137 | M |
| SA192084 | D-131 | M |
| SA192085 | D-133 | M |
| SA192086 | D-139 | M |
| SA192087 | D-160 | M |
| SA192088 | D-161 | M |
| SA192089 | D-159 | M |
| SA192090 | D-158 | M |
| SA192091 | D-157 | M |
| SA192092 | D-129 | M |
| SA192093 | D-141 | M |
| SA192094 | D-142 | M |
| SA192095 | D-148 | M |
| SA192096 | D-162 | M |
| SA192097 | D-136 | M |
| SA192098 | D-147 | M |
| SA192099 | D-145 | M |
| SA192100 | D-146 | M |
| SA192101 | D-149 | M |
| SA192102 | D-150 | M |
| SA192103 | D-134 | M |
| SA192104 | D-143 | M |
| SA192105 | D-144 | M |
| SA192106 | D-151 | M |
| SA192107 | D-138 | M |
| SA192108 | D-135 | M |
| SA192109 | D-174 | M |
| SA192110 | D-193 | M |
| SA192111 | D-194 | M |
| SA192112 | D-195 | M |
| SA192113 | D-192 | M |
| SA192114 | D-191 | M |
| SA192115 | D-187 | M |
| SA192116 | D-189 | M |
| SA192117 | D-190 | M |
| SA192118 | D-196 | M |
| SA192119 | D-197 | M |
| SA192120 | NHF-87 | M |
| SA192121 | NHF-88 | M |
| SA192122 | NHF-89 | M |
| SA192123 | NHF-81 | M |
| SA192124 | NHF-48 | M |
| SA192125 | D-198 | M |
| SA192126 | NHF-15 | M |
| SA192127 | NHF-44 | M |
| SA192128 | D-186 | M |
| SA192129 | D-184 | M |
| SA192130 | D-170 | M |
| SA192131 | D-171 | M |
| SA192132 | D-172 | M |
| SA192133 | D-169 | M |
| SA192134 | D-167 | M |
| SA192135 | D-3 | M |
| SA192136 | D-165 | M |
| SA192137 | D-166 | M |
| SA192138 | D-173 | M |
| SA192139 | D-128 | M |
| SA192140 | D-181 | M |
| SA192141 | D-182 | M |
| SA192142 | D-183 | M |
Collection:
| Collection ID: | CO002119 |
| Collection Summary: | Serum samples were collected from CVD patients at the Safdarjung Hospital, New Delhi. In all assessments, all individuals were asked to provide complete information regarding personal health history, self-rated health, and family history of diabetes, tobacco use, and physical activity. Ethical approval was obtained at Safdarjung Hospital, New Delhi for sample collection. |
| Sample Type: | Blood (serum) |
Treatment:
| Treatment ID: | TR002138 |
| Treatment Summary: | NA |
Sample Preparation:
| Sampleprep ID: | SP002132 |
| Sampleprep Summary: | Serum samples (100µl) should be properly thawed and spin at 5K rpm for one minute, added with 100 % MeOH (300µl, in1:3 ratio) and vortex well (30s), incubated on ice for 10 minutes and then centrifuged at 10K rpm for 10 minutes at 4℃. Equally, transfer the supernatant into two different well-labeled tubes and then speed vacuum dry and stored at -80℃. One set of the tubes is used for the analysis of polar metabolites and the other one is used for the non-polar metabolites. For the reconstitution of polar metabolites, 50% ACN (50 µl) is added into the vacuum dried sample and for nonpolar 15% of MeOH (50 µl) is used. After the addition of reconstitutes, vortex well for 10 min and centrifuged at 10K rpm for 10 minutes at 4℃ and transfer the supernatant (approx. 40-45 µl) into MS vials. Remove 10µl form every sample containing MS vials and pooled together into a 15 ml tube to use as QC. Then, the samples were stored at -80℃ for further analysis. |
Chromatography:
| Chromatography ID: | CH002464 |
| Chromatography Summary: | For hydrophilic interaction (HILIC) chromatography, 5 µl of the prepared samples were injected for analysis. An ultimate 3000 UPLC XBridge BHE Amide column (2.1 x 100 mm, 2.5 µm; Waters Corporation) was used and maintained at 35℃ for separation. The mobile phase was delivered at 0.35mL/min. The mobile phase A consisted of 20mM ammonium acetate in the water of pH 9.0 and mobile phase B was 100% acetonitrile. The elution gradient is used as follows: 0 min-85% B, 2 min-10% B, 14 min- 10% B, 14.1 min- 85% B, 16 min- 85%B. |
| Instrument Name: | Thermo Dionex Ultimate 3000 |
| Column Name: | Waters Xbridge BEH HILIC (75 x 2.1mm,2.5um) |
| Column Temperature: | 35 |
| Flow Gradient: | 0 min-85% B, 2 min-10% B, 14 min- 10% B, 14.1 min- 85% B, 16 min- 85%B. |
| Flow Rate: | 0.35mL/min |
| Solvent A: | 100% water; 20 mM ammonium acetate, pH 9.0 |
| Solvent B: | 100% acetonitrile |
| Chromatography Type: | HILIC |
| Chromatography ID: | CH002465 |
| Chromatography Summary: | For reversed-phase (RP) chromatographic analyses, 5 µL of prepared samples were injected. The separation was performed using a UPLC ultimate 3000 using the HSS T3 column (2.1x 100mm, 1.7 µm; Waters Corporation) at 40℃. The mobile phase was delivered at 300µL/min and consisted of eluent A (water with 0.1%formic acid) and eluent B (acetonitrile with 0.1% formic acid), delivered in a gradient profile: 0min-1% B, 1min-15%B, 4min-35% B, 7min-95% B, 9 min- 95% B, 10min-1% B, 14 min- 1% B. |
| Instrument Name: | Thermo Dionex Ultimate 3000 |
| Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
| Flow Gradient: | 0min-1% B, 1min-15%B, 4min-35% B, 7min-95% B, 9 min- 95% B, 10min-1% B, 14 min- 1% B |
| Flow Rate: | 300µL/min |
| Solvent A: | 100% water; 0.1%formic acid |
| Solvent B: | 100% acetonitrile; 0.1% formic acid |
| Chromatography Type: | Reversed phase |
Analysis:
| Analysis ID: | AN003325 |
| Analysis Type: | MS |
| Chromatography ID: | CH002464 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST002044_AN003325_Results.txt |
| Units: | peak height |
| Analysis ID: | AN003326 |
| Analysis Type: | MS |
| Chromatography ID: | CH002464 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST002044_AN003326_Results.txt |
| Units: | peak height |
| Analysis ID: | AN003327 |
| Analysis Type: | MS |
| Chromatography ID: | CH002465 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST002044_AN003327_Results.txt |
| Units: | peak height |
| Analysis ID: | AN003328 |
| Analysis Type: | MS |
| Chromatography ID: | CH002465 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST002044_AN003328_Results.txt |
| Units: | peak height |